GSK | ||
---|---|---|
OUTLOOK RATING 1..100 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 62 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 56 | |
P/E GROWTH RATING 1..100 | 26 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GINX | GSK | |
---|---|---|
RSI ODDS (%) | 2 days ago40% | 2 days ago44% |
Stochastic ODDS (%) | 2 days ago60% | 2 days ago46% |
Momentum ODDS (%) | 2 days ago73% | 2 days ago67% |
MACD ODDS (%) | 2 days ago63% | 2 days ago71% |
TrendWeek ODDS (%) | 2 days ago87% | 2 days ago60% |
TrendMonth ODDS (%) | 2 days ago83% | 2 days ago53% |
Advances ODDS (%) | 2 days ago88% | 2 days ago59% |
Declines ODDS (%) | 4 days ago59% | N/A |
BollingerBands ODDS (%) | 2 days ago58% | 2 days ago51% |
Aroon ODDS (%) | 2 days ago87% | 2 days ago44% |
A.I.dvisor tells us that GINX and GSK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and GSK's prices will move in lockstep.
Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
---|---|---|---|---|
GINX | 100% | +0.15% | ||
GSK - GINX | 23% Poorly correlated | +2.25% | ||
BHP - GINX | 22% Poorly correlated | +0.07% | ||
KMB - GINX | 21% Poorly correlated | +1.55% | ||
RELX - GINX | 21% Poorly correlated | +0.53% | ||
KO - GINX | 20% Poorly correlated | -0.42% | ||
More |
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with AZN. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then AZN could also see price increases.